Palleon Pharmaceuticals
PrivateLast Round
Series B
Sep 17, 2020
Est. Valuation
$238.83M
Total Funding Raised
$147.6M
Company Overview
Palleon Pharmaceuticals is a biotechnology company that develops glyco-immunology therapeutics to treat cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Palleon Pharmaceuticals Comparables
Compare Palleon Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OncoC4, Inc. | 81% | |
| Valora Therapeutics Inc. | 79% | |
| Tacalyx | 77% | |
Palleon Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 17, 2020 | ||||
| Series A | Oct 4, 2017 |
Key People
Founding team and executive leadership
Palleon Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series B |
| Vertex Ventures HC | Series A, Series B |
| AbbVie Ventures | Series A, Series B |
| Citadel | Series B |
| Matrix Capital Management | Series B |
| Pfizer Ventures | Series B, Series A |
| Takeda Ventures | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Presented B7-H3 Targeted Sialidase at the 2026 AACR Annual Meeting.
- Apr 2, 2026
Presenting product candidate HLX316/E-688 at AACR Annual Meeting.
Palleon Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Palleon Pharmaceuticals's valuation, stock price, and market status.